GlucoTrack (GCTK) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced at 12:00 P.M. Eastern Time, presided over by the CEO, with directors and outside counsel present.

• Agenda was adopted and outlined for the meeting, with official business to be conducted in order.

Shareholder proposals

• Two proposals were presented: approval of NASDAQ stock issuance under an ELOC agreement and approval of stock issuance for bridge financing.

• Both proposals were discussed in accordance with the proxy statement, with participation limited to stockholders and proxies.

Overview of voting outcomes

• Quorum was established with 34.61% of eligible votes represented.

• Both proposals received the requisite number of votes for approval.

• Approval included full issuance of shares to White Lion Capital LLC and bridge investors, in compliance with NASDAQ Listing Rule 5635(d).

• Final voting results will be reported to the SEC on Form 8-K within four business days.